v3.20.4
Integration and Restructuring Plans (Tables)
 12 Months Ended
Dec. 31, 2020
Allergan integration plan  
Restructuring charges  
Summary of charges associated with integration plan
The following table summarizes the charges associated with the Allergan acquisition integration plan:
2020
year ended December 31 (in millions)Severance and employee benefitsOther integration
Cost of products sold$109 $21 
Research and development199 177 
Selling, general and administrative388 237 
Total charges$696 $435 
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the recorded liability associated with the integration plan:
2020
year ended December 31 (in millions)Severance and employee benefitsOther integration
Charges$594 $435 
Payments and other adjustments(227)(415)
Accrued balance as of December 31, 2020$367 $20 
Other restructuring  
Restructuring charges  
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for 2020, 2019 and 2018:
(in millions)
Accrued balance as of December 31, 2017$86 
2018 restructuring charges
59 
Payments and other adjustments(46)
Accrued balance as of December 31, 201899 
2019 restructuring charges
219 
Payments and other adjustments(178)
Accrued balance as of December 31, 2019140 
2020 restructuring charges
58 
Payments and other adjustments(108)
Accrued balance as of December 31, 2020$90